X‐ray controlled release strategy in cancer therapy
BMEMat · 2025-12 · 3 (4)
DOI: 10.1002/bmm2.12136 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMEMat, online erschienen am 16.01.2025. Verfasst von Yiling Ruan und 5 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Construction of drug carriers or prodrugs is a common approach to improve the pharmacokinetics of molecular drugs and enhance the tumor curative effect. Nanocarriers that can be activated by the tumor microenvironment including enzymes, pH, redox status, or external stimuli such as ultraviolet, ultrasound, and magnetism, are booming. As a commonly used clinical theranostic approach with excellent spatiotemporal controllability and deep tissue penetration, X‐ray has attracted much attention as an external stimulus in recent years. The rapid development of nanomaterials as radiosensitizers or radioluminescents further accelerates the construction of X‐ray‐responsive nanocarriers. In this review, the currently developed X‐ray activated drug release systems in cancer therapy are summarized with a focus on controlled release design.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ruan, Y., Huang, H., Liu, H., Gong, J., Li, C., & Sun, X. (2025). X‐ray controlled release strategy in cancer therapy. BMEMat, 3(4). https://doi.org/10.1002/bmm2.12136
Vancouver
Ruan Y, Huang H, Liu H, Gong J, Li C, Sun X. X‐ray controlled release strategy in cancer therapy. BMEMat. 2025;3(4). doi:10.1002/bmm2.12136
BibTeX
@article{Ruan2025,
author = {Ruan, Yiling and Huang, Hongxiang and Liu, Huihui and Gong, Jinglang and Li, Changjun and Sun, Xiaolian},
title = {X‐ray controlled release strategy in cancer therapy},
journal = {BMEMat},
year = {2025},
volume = {3},
number = {4},
doi = {10.1002/bmm2.12136}
}
EUVIMED